Literature DB >> 33291839

Network and Evolutionary Analysis of Human Epigenetic Regulators to Unravel Disease Associations.

Shinji Ohsawa1,2, Toshiaki Umemura3, Tomoyoshi Terada1,4, Yoshinori Muto1,4.   

Abstract

We carried out a system-level analysis of epigenetic regulators (ERs) and detailed the protein-protein interaction (PPI) network characteristics of disease-associated ERs. We found that most diseases associated with ERs can be clustered into two large groups, cancer diseases and developmental diseases. ER genes formed a highly interconnected PPI subnetwork, indicating a high tendency to interact and agglomerate with one another. We used the disease module detection (DIAMOnD) algorithm to expand the PPI subnetworks into a comprehensive cancer disease ER network (CDEN) and developmental disease ER network (DDEN). Using the transcriptome from early mouse developmental stages, we identified the gene co-expression modules significantly enriched for the CDEN and DDEN gene sets, which indicated the stage-dependent roles of ER-related disease genes during early embryonic development. The evolutionary rate and phylogenetic age distribution analysis indicated that the evolution of CDEN and DDEN genes was mostly constrained, and these genes exhibited older evolutionary age. Our analysis of human polymorphism data revealed that genes belonging to DDEN and Seed-DDEN were more likely to show signs of recent positive selection in human history. This finding suggests a potential association between positive selection of ERs and risk of developmental diseases through the mechanism of antagonistic pleiotropy.

Entities:  

Keywords:  antagonistic pleiotropy; cancer disease; co-expression module; developmental disease; evolutionary rate; positive selection; protein–protein interaction

Year:  2020        PMID: 33291839      PMCID: PMC7761991          DOI: 10.3390/genes11121457

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  68 in total

Review 1.  DNA methylation patterns and epigenetic memory.

Authors:  Adrian Bird
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 2.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

Review 3.  Epigenome in Early Mammalian Development: Inheritance, Reprogramming and Establishment.

Authors:  Qianhua Xu; Wei Xie
Journal:  Trends Cell Biol       Date:  2017-12-05       Impact factor: 20.808

Review 4.  An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy.

Authors:  Mark J Millan
Journal:  Neuropharmacology       Date:  2012-12-11       Impact factor: 5.250

Review 5.  Insights from epigenetic studies on human health and evolution.

Authors:  Connie J Mulligan
Journal:  Curr Opin Genet Dev       Date:  2018-07-04       Impact factor: 5.578

6.  FACER: comprehensive molecular and functional characterization of epigenetic chromatin regulators.

Authors:  Jianping Lu; Juan Xu; Junyi Li; Tao Pan; Jing Bai; Liqiang Wang; Xiyun Jin; Xiaoyu Lin; Yunpeng Zhang; Yongsheng Li; Nidhi Sahni; Xia Li
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

7.  Dynamics of epigenetic regulation at the single-cell level.

Authors:  Lacramioara Bintu; John Yong; Yaron E Antebi; Kayla McCue; Yasuhiro Kazuki; Narumi Uno; Mitsuo Oshimura; Michael B Elowitz
Journal:  Science       Date:  2016-02-12       Impact factor: 47.728

Review 8.  Antagonistic Pleiotropy in Human Disease.

Authors:  Sean G Byars; Konstantinos Voskarides
Journal:  J Mol Evol       Date:  2019-12-21       Impact factor: 3.973

9.  Systems Level Analysis and Identification of Pathways and Key Genes Associated with Delirium.

Authors:  Yukiko Takahashi; Tomoyoshi Terada; Yoshinori Muto
Journal:  Genes (Basel)       Date:  2020-10-19       Impact factor: 4.096

Review 10.  SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.

Authors:  Karolin Eifler; Alfred C O Vertegaal
Journal:  Trends Biochem Sci       Date:  2015-10-22       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.